These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8239697)
1. [Usefulness of BFP for screening of early urinary bladder cancer]. Ishii M; Seino Y; Tari K Gan To Kagaku Ryoho; 1993 Nov; 20(14):2255-7. PubMed ID: 8239697 [No Abstract] [Full Text] [Related]
2. [Clinical evaluation of urinary basic fetoprotein and the BTA test for detection of bladder cancer]. Imamura M; Inoue K; Megumi Y; Nishimura M; Ohmori K; Nishimura K Hinyokika Kiyo; 2000 Oct; 46(10):705-9. PubMed ID: 11215195 [TBL] [Abstract][Full Text] [Related]
4. Clinical study of urine NMP 22 (nuclear matrix protein 22) as a tumor marker in urinary epithelial cancer. Takeuchi Y; Sawada Y; Yabuki D; Masuda E; Satou D; Kuroda K; Tajima M; Sawamura Y; Matsushima M Aktuelle Urol; 2003 Jul; 34(4):265-6. PubMed ID: 14566681 [TBL] [Abstract][Full Text] [Related]
5. [Urinary tumor marker for urothelial cancer]. Ohtani M; Iwasaki A; Shiraiwa H Gan To Kagaku Ryoho; 2001 Nov; 28(12):1933-7. PubMed ID: 11729491 [TBL] [Abstract][Full Text] [Related]
6. A promising bladder cancer detection assay: the HA-HAase test. Ho SM; Cheng RY J Urol; 2004 Sep; 172(3):824-5. PubMed ID: 15310975 [No Abstract] [Full Text] [Related]
7. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer. Sánchez-Carbayo M; Urrutia M; Silva JM; Romanà R; De Buitrago JM; Navajo JA J Urol; 2001 May; 165(5):1462-7. PubMed ID: 11342897 [TBL] [Abstract][Full Text] [Related]
12. The use of urine-based biomarkers in bladder cancer. Grossman HB; Blute ML; Dinney CP; Jones JS; Liou LS; Reuter VE; Soloway MS Urology; 2006 Mar; 67(3 Suppl 1):62-4. PubMed ID: 16530080 [No Abstract] [Full Text] [Related]
13. Urine test boosts detection of recurrent bladder cancer. Hilton L RN; 2006 Apr; 69(4):3-4. PubMed ID: 16640017 [No Abstract] [Full Text] [Related]
14. Quick test for recurrent bladder cancer. Health News; 2006 Apr; 12(4):13. PubMed ID: 16583496 [No Abstract] [Full Text] [Related]
15. Urine detection of survivin and diagnosis of bladder cancer. Moore M J Insur Med; 2001; 33(2):202-3. PubMed ID: 11510521 [No Abstract] [Full Text] [Related]
16. [Screening methods in the detection of bladder cancer: comparison of nuclear matrix protein-22, bladder tumor antigen and cytological examinations]. Fukui Y; Samma S; Fujimoto K; Akiyama T; Yamaguchi A; Hirayama A Hinyokika Kiyo; 2001 May; 47(5):311-4. PubMed ID: 11433750 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group]. Akaza H; Miyanaga N; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K Gan To Kagaku Ryoho; 1997 May; 24(7):829-36. PubMed ID: 9170521 [TBL] [Abstract][Full Text] [Related]